ATE358128T1 - Vorbeugende oder therapeutische mittel gegen gastrische oder ösophageale regurgitation - Google Patents

Vorbeugende oder therapeutische mittel gegen gastrische oder ösophageale regurgitation

Info

Publication number
ATE358128T1
ATE358128T1 AT01902793T AT01902793T ATE358128T1 AT E358128 T1 ATE358128 T1 AT E358128T1 AT 01902793 T AT01902793 T AT 01902793T AT 01902793 T AT01902793 T AT 01902793T AT E358128 T1 ATE358128 T1 AT E358128T1
Authority
AT
Austria
Prior art keywords
group
preventive
therapeutic agents
agents against
against gastric
Prior art date
Application number
AT01902793T
Other languages
English (en)
Inventor
Satoshi Yamazaki
Original Assignee
Mitsubishi Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Pharma Corp filed Critical Mitsubishi Pharma Corp
Application granted granted Critical
Publication of ATE358128T1 publication Critical patent/ATE358128T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4743—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT01902793T 2000-02-09 2001-02-07 Vorbeugende oder therapeutische mittel gegen gastrische oder ösophageale regurgitation ATE358128T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000031542 2000-02-09

Publications (1)

Publication Number Publication Date
ATE358128T1 true ATE358128T1 (de) 2007-04-15

Family

ID=18556282

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01902793T ATE358128T1 (de) 2000-02-09 2001-02-07 Vorbeugende oder therapeutische mittel gegen gastrische oder ösophageale regurgitation

Country Status (13)

Country Link
US (7) US6967207B2 (de)
EP (1) EP1256581B1 (de)
JP (1) JP4781592B2 (de)
KR (1) KR100750437B1 (de)
AT (1) ATE358128T1 (de)
AU (1) AU2001230588A1 (de)
CA (1) CA2399818C (de)
DE (1) DE60127535T2 (de)
DK (1) DK1256581T3 (de)
ES (1) ES2284612T3 (de)
PT (1) PT1256581E (de)
TW (1) TWI256314B (de)
WO (1) WO2001058898A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI256314B (en) * 2000-02-09 2006-06-11 Mitsubishi Pharma Corp Preventive-therapeutical medicament for gastroesophageal reflux disease
EP1829543B1 (de) * 2001-08-24 2009-01-21 Mitsubishi Tanabe Pharma Corporation Mittel zur Prävention und Behandlung des vorwiegend durch Obstipation geprägten Reizdarms
WO2003020728A1 (en) 2001-08-30 2003-03-13 Pharmacia & Upjohn Company 4-THIOXO-4,7-DIHYDRO-THIENO[2,3-b]PYRIDINE-5-CARBOTHIOAMIDES AS ANTIVIRAL AGENTS
MXPA04003007A (es) * 2001-10-02 2004-07-15 Upjohn Co Compuestos azabiciclico sustituidos condensados con heteroarilo para el tratamiento de enfermedades.
AR038117A1 (es) 2002-01-14 2004-12-29 Upjohn Co Agentes antivirales derivados de la 4- oxo-4,7 -dihidrofuro [2,3-b]piridin-5-carboxamida
AR038294A1 (es) * 2002-01-14 2005-01-12 Upjohn Co Oxotieno(3,2-b)piridincarboxamidas como agentes antivirales
AR038118A1 (es) 2002-01-14 2004-12-29 Upjohn Co Compuestos derivados de la bencinamida del acido 7-oxo-4,7-dihidrotien[2,3-b[piridin-6-carboxilico 3-sustituido que son utiles como antivirales
KR20060118421A (ko) * 2003-08-29 2006-11-23 다이노젠 파마세우티컬스, 인코포레이티드 위장 운동 장애의 치료에 유용한 조성물
US8642067B2 (en) 2007-04-02 2014-02-04 Allergen, Inc. Methods and compositions for intraocular administration to treat ocular conditions
US20090131471A1 (en) * 2007-06-07 2009-05-21 Dynogen Pharmaceuticals, Inc. Compositions useful for treating gastroesophageal reflux disease
AU2010273732A1 (en) 2009-07-14 2012-02-09 Albany Molecular Research, Inc. 5-HT3 receptor modulators, methods of making, and use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4829073A (en) * 1988-05-12 1989-05-09 Bristol-Myers Company Thiadiazole oxides for treating gastrointestinal motility disorders
CA2028002A1 (en) * 1989-10-19 1991-04-20 Daniel P. Becker Method of treating gastrointestinal motility disorders
JP2699794B2 (ja) * 1992-03-12 1998-01-19 三菱化学株式会社 チエノ〔３，２−ｂ〕ピリジン誘導体
SE9603408D0 (sv) * 1996-09-18 1996-09-18 Astra Ab Medical use
TWI256314B (en) * 2000-02-09 2006-06-11 Mitsubishi Pharma Corp Preventive-therapeutical medicament for gastroesophageal reflux disease

Also Published As

Publication number Publication date
DK1256581T3 (da) 2007-09-24
CA2399818A1 (en) 2001-08-16
US20100204267A1 (en) 2010-08-12
US20100210679A1 (en) 2010-08-19
EP1256581B1 (de) 2007-03-28
US20050282852A1 (en) 2005-12-22
DE60127535D1 (de) 2007-05-10
PT1256581E (pt) 2007-06-26
KR100750437B1 (ko) 2007-08-21
US20100168157A1 (en) 2010-07-01
US20030130304A1 (en) 2003-07-10
CA2399818C (en) 2010-01-12
WO2001058898A1 (en) 2001-08-16
DE60127535T2 (de) 2007-12-06
US20080293762A1 (en) 2008-11-27
KR20020089340A (ko) 2002-11-29
ES2284612T3 (es) 2007-11-16
EP1256581A4 (de) 2004-10-06
US6967207B2 (en) 2005-11-22
EP1256581A1 (de) 2002-11-13
US20060281781A1 (en) 2006-12-14
TWI256314B (en) 2006-06-11
AU2001230588A1 (en) 2001-08-20
JP4781592B2 (ja) 2011-09-28

Similar Documents

Publication Publication Date Title
CY1111951T1 (el) Φαινυλο-καρβοξαμιδικες ενωσεις χρησιμες για την αντιμετωπιση πονου
ATE440603T1 (de) 8-hydroxychinolinderivate
NO20071042L (no) 5-substituerte 2-fenylaminobenzamider som MEK-inhibitorer
NO20020968D0 (no) Glukopyranosyloksypyrazolderivater, medisinske sammensetninger inneholdende det samme og intermediater forfremstillingen derav
IL205420A (en) Immunogoldular and Derivative Compounds, Pharmaceutical Compounds in the Treatment of Inflammatory Stomach and Gastrointestinal Disorders
DK1065204T3 (da) Bicykliske carbonyl-indolforbindelser som anti-inflammatoriske/analgesiske midler og som COX-2-inhibitorer
ATE358128T1 (de) Vorbeugende oder therapeutische mittel gegen gastrische oder ösophageale regurgitation
EA200501703A1 (ru) Применение производных азетидинкарбоксамида в терапии
JP2003502367A5 (de)
NO20025035D0 (no) Oksadiazolderivater som har anticancer-effekter
DE60035429D1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
RU98119076A (ru) Производные 2-(3h)-оксазолона и их применение в качестве ингибиторов сох-2
RU2004103475A (ru) Производные арил-или гетероарилазолилкарбинолов для лечения недержания мочи
EP1152004A4 (de) Derivate der phosphonsäure zur inhibierung von carboxypeptidase b
IL150965A0 (en) Therapeutic or preventive agent for digestive system diseases containing a diaminotrifluoromethylpyridine derivative
NO20025659D0 (no) Heterocykliske forbindelser
ATE293961T1 (de) Verwendung von hydantoin und seinen derivaten gegen hypalbuminämie
DE60126199D1 (de) Therapeutische behandlung von eosinophilie durch verwendung von chymase-inhibitoren als aktiven bestandteilen
ATE511395T1 (de) Mittel zur behandlung von glomerulopathie
ATE447953T1 (de) Pharmazeutische zusammensetzungen zur behandlung von leishmaniasis
WO2007000392A3 (en) Chloro-substituted guanidines
SI1553938T1 (sl) Uporaba epotilonskih derivatov za zdravljenje hiperparatiroidizma

Legal Events

Date Code Title Description
EEIH Change in the person of patent owner
UEP Publication of translation of european patent specification

Ref document number: 1256581

Country of ref document: EP

REN Ceased due to non-payment of the annual fee